Value Propositions
- Application and Population Management System Undergoing Testing for the Management of Flares in Patients with Rheumatoid Arthritis
- Humana Adds MDLIVE Telemedicine Technology Benefit to Select Medicare Advantage Plans
- Applications Being Developed to Provide Patients with Timely Drug Cost Information
- Routine Monitoring of Drug Levels and Antidrug Antibodies Benefits Cost, Improves Treatment Decision-Making
- Switching Between Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
- Tofacitinib Treatment Demonstrates Cost Benefits in Patients with Rheumatoid Arthritis
- Portable Device Offers Easier, Cost-Effective Approach to Gout Diagnosis
- Efficacy and Safety Maintained for Up to 5 Years with Tocilizumab Therapy
- First Ever Treatment Guidelines for Managing Rheumatologic Manifestations of Sjögren’s Syndrome
- Short-Term Use of Soft Lateral Wedge Arch Support Significantly Reduces Pain in Patients with Knee Osteoarthritis
- Tocilizumab Effective, Highly Retentive in Patients with Rheumatoid Arthritis
- Cardiovascular Screening Cost-Effective in Patients with Rheumatoid Arthritis
- Decernotinib, DMARD Combination Reduces Symptoms, Signs of Rheumatoid Arthritis
- Efficacy of Etanercept, Methotrexate Combination Independent of Methotrexate Dosage
- Rapid Access Rheumatology Consultations Feasible, Beneficial
- Etanercept plus MTX More Cost-Effective than Monotherapy in Patients with Severe JIA
- Higher Costs Linked to Lower DMARD Initiations, Refills in MAPD Members with RA
- Higher Social Support Associated with Less Depression in Older Patients with RA
- Home
- Issues
- 2018
- 2017
- December 2017, Vol 6, No 5
- October 2017, Vol 6, No 4
- August 2017, Vol 6, No 3
- June 2017, Vol 6, No 2
- April 2017, Vol 6, No 1
- 2016
- December 2016, Vol 5, No 6
- October 2016, Vol 5, No 5
- August 2016, Vol 5, No 4
- June 2016, Vol 5, No 3
- April 2016, Vol 5, No 2
- February 2016, Vol 5, No 1
- Issues Archive
- Supplements
- Categories
- Web Exclusives
- About
